<DOC>
	<DOCNO>NCT02316665</DOCNO>
	<brief_summary>Hypothesis : To address role continuous positive airway pressure ( CPAP ) nocturnal glycemia patient type 1 diabetes sleep apnea syndrome . Investigators make hypothesis sleep apnea syndrome impact nocturnal glycemia type 1 diabetic patient continuous positive airway pressure treatment permit improve nocturnal glycemic profile . Study design : Adult patient type 1 diabetes recruit extensive study sleep habit assessment sleep breathing disorder . When patient present severe sleep apnea syndrome ( apnea-hypopnea index 30 events/hour ) insufficient glycemic control ( HbA1c &gt; 7.5 % ) , randomize continuous positive airway pressure treatment sham-continuous positive airway pressure treatment group three month . Main outcome : Nocturnal glycemic control assess 5 day three month allocate treatment .</brief_summary>
	<brief_title>Effect Sleep Apnea Treatment Type 1 Diabetes</brief_title>
	<detailed_description>Quality clinical study procedure check on-site audit . Patient self-reported past medical history check review medical record . Paper case report form use . For baseline extensive study sleep habit , follow data record : - Self-reported sleep diary ( 7 day ) - Actimetric device ( 7 day ) - Munich Chronotype Questionnaire - 24h-dietary recall - Salivary collection every 30 minute 7:30 pm 22:00 pm one night address dim light melatonin onset . - Other questionnaire : Job strain questionnaire , EPICES ( precarity questionnaire ) DQOL ( diabetes relate quality life ) - Nocturnal oxymetry Blood measurement : HbA1c , lipidic profile , microalbuminuria , creatinin After baseline assessment , patient abnormal nocturnal oximetry explore polysomnography order detect sleep apnea syndrome . Investigators anticipate , base previous pilot study group ( `` Borel '' Diab Med 2010 ) , 30 % screen patient present sleep apnea . If patient present severe sleep apnea ( IAH &gt; 30 events/hour ) HbA1c &gt; 7.5 % , randomize intervention . Sample size : base previous study `` Pallayova '' et al . patient type 2 diabetes , investigator anticipate difference group 1.3 ( SD 2.07 ) mean nocturnal glycemia . For alpha threshold 5 % study power 80 % , study include 32 patient group . Taking account possible 25 % dropout study need include 40 patient randomized arm demonstrate effect . Statistical analysis : An intention-to-treat analysis perform . Missing data continuous positive airway pressure group replace median value three-month sham-continuous positive airway pressure group reciprocally . In second analysis , per-protocol analysis perform limited patient complete treatment allocate group adherence continuous positive airway pressure sham-continuous positive airway pressure treatment 4-hours night . Normality data check Kurtosis Skewness test . The significance level set 5 % .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Adult patient type 1 diabetes Pregnant woman Patient acute metabolic disorder past three month Shift worker Institutionalized patient Enteral parenteral nutrition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Sleep apnea syndrome</keyword>
	<keyword>Nocturnal glycemia</keyword>
	<keyword>Continuous glucose monitoring system</keyword>
	<keyword>Continuous positive airway pressure</keyword>
	<keyword>Sleep habit</keyword>
</DOC>